HilleVax $200 million IPO
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Owens & Minor $600 million notes offering
The high-yield notes are due 2030
AN2 Therapeutics $69 million IPO
The shares are listed on the Nasdaq Global Select Market
Roche Holdings $5 billion notes offering
We advised Roche on the Rule 144A / Regulation S offering comprising five tranches of notes
Denali $400 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Silver Spike Acquisition Corp. II combination with Eleusis
We are advising the SPAC on the transaction
ProKidney combination with Social Capital Suvretta Holdings Corp. III
We are advising ProKidney on the transaction
Biodesix $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Legend Biotech $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Dynamics Special Purpose $601 million combination with Senti Biosciences
We are advising Dynamics, a SPAC, on the transaction